Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases. [electronic resource]
Producer: 20040122Description: 281-7 p. digitalISSN:- 0190-9622
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- metabolism
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Agents, Alkylating -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Flow Cytometry
- Humans
- Lymphoma, B-Cell -- drug therapy
- Male
- Middle Aged
- Recurrence
- Rituximab
- Skin Neoplasms -- drug therapy
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.